Recent studies have also described elevated CD47 levels in tissue-infiltrating NK cells and CD8+ T cells in esophageal carcinoma patients (21), but the impact of anti-CD47 treatments on lymphocyte and particularly effector T cells in patients has not been extensively documented. Here, CD47 is linked to carcinoma of esophagus.